CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy EVP Finance bought 100 shares at $5.25 ($525)
- 4 Open-market buy Chief Development Officer bought 1,431 shares at $5.29 ($7,570)
- 4 Open-market buy Director bought 5,260 shares at $4.88 ($25,669)
- 4 Open-market buy President and CEO bought 3,000 shares at $5.00 ($14,997)
- 4 Grant or award EVP Finance acquired 30,000 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 62,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP Finance acquired 2,400 shares (grant or award)
- 4 Grant or award President and CEO acquired 15,600 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 15,600 shares (grant or award)
Page 3 of 21 · 406 filings